🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Double-blind randomized controlled clinical trial (RCT) of low-dose lenalid...
Status
Unknown
Location
Hospital Universitario de Getafe
Start Date
2020-10-27
Trial ID
NCT04361643
Treatments Being Tested
Population in Chile has experienced an accelerated process of demographic a...
Status
Completed
Location
Universidad de Concepción
Start Date
2017-10-10
Trial ID
NCT03924115
Treatments Being Tested
Clostridium difficile infection (CDI) is one of the most urgent health thre...
Status
Terminated
Location
Boston Medical Center
Start Date
2019-08-23
Trial ID
NCT03795233
Treatments Being Tested
This study aims at identifying analysis strategies to detect oral administr...
Status
Completed
Location
IMIM
Start Date
2018-05-22
Trial ID
NCT03537326
Treatments Being Tested
The XEN1101 Phase 1 clinical trial is a randomized, double-blind, placebo-c...
Status
Completed
Location
King's College Hospital
Start Date
2018-02-13
Trial ID
NCT03468725
Treatments Being Tested
This Phase 2 proof-of-concept study is a double-blind, randomized, placebo-...
Status
Completed
Location
VA San Diego Healthcare System/ University of California, San Diego
Start Date
2011-04
Trial ID
NCT01339689
Treatments Being Tested
A phase 2b, multicenter, randomized, double-blind, placebo-controlled study...
Status
Completed
Location
The Institute for Liver Health (Arizona Liver Health)
Start Date
2022-12-27
Trial ID
NCT05623189
The goal of this double-blind, randomized placebo-controlled study is to ev...
Status
Recruiting
Location
KGK Science Inc.
Start Date
2025-06-16
Trial ID
NCT06937814
Treatments Being Tested
The primary objective of the study was to evaluate the safety and tolerabil...
Status
Completed
Location
Multiple Locations
Start Date
2009-03
Trial ID
NCT00865904
This is a 16-week, multicenter, randomized, parallel-group, double-blind, c...
Status
Completed
Location
Clinical Trial Site 15
Start Date
2022-03-29
Trial ID
NCT05343455
Treatments Being Tested